Latest Insights on ORIC
The Formula for Limiting Losses September 22, 2021 Big Picture. Big Profits., Trading Strategies, U.S. Economy I was great at buying the right stocks but was still a terrible investor. Maybe it’s the same for you? For example, in October 2016, I bought Advanced Micro Devices (Nasdaq: AMD). I looked like a genius. AMD gained over 1,000% since I bought into the stock. But I missed all of those gains! So much for looking like a genius. What happened? Simply put: I trusted my gut. And it cost me a lot of lost gains. So how do we stop that from happening to you?
Feeling Lost? Let Us Find the Path to Gains September 22, 2021 Trading Strategies, True Options Masters Chris Cimorelli found himself lost in downtown Baltimore... and it got him thinking about our purpose in True Options Masters.
Boeing Catches Ryanair, Match Strikes Tinder & Terminator X It September 7, 2021 Great Stuff Boeing: Trade Me Deadly I went to a party last Saturday night. I didn’t get picks … got in a fight. Uh-huh … it ain’t no big thing. Ryanair killed an order; Boeing prices are bad. Can’t borrow ten bucks from your old man? Uh-huh … it ain’t no big thing. But I know what […]
3 Important Reminders September 6, 2021 Big Picture. Big Profits., Investing, News Happy Labor Day to you. Hopefully you are enjoying some time with friends and family.
The markets are closed today and our team is enjoying a much-needed break.
So, instead of your regular Your Money Matters video today, let’s revisit three of our most useful videos to help you navigate one of the most challenging investing environments we’ve ever seen.
Which Is Better: Growth Stocks or Lottery Tickets? September 3, 2021 Big Picture. Big Profits., Investing, U.S. Economy Growth stocks are back in recent weeks. After a difficult first half, shares of “next big thing” companies are rebounding. Fed Chairman Powell’s “hold the course” speech helped. But is this a signal to jump back into companies that may only produce a profit years from now? A recent article from leading research outfit GMO gives five reasons — based on historical evidence — why now may be the riskiest time in two decades to do just that.





